NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Twitter Acquisition Lawsuit Verdict

A San Francisco jury has found Elon Musk liable for misleading investors by intentionally driving down Twitter's stock price in the months leading up to his 2022 acquisition of the social media company for $44 billion. The verdict was delivered after 3 days of deliberation, nearly three weeks after the trial began on March 2.

The civil trial centered on a class-action lawsuit filed just before Musk took control of Twitter, which he later renamed X. The jury was asked to decide if two tweets and comments Musk made on a podcast in May 2022 amounted to him intentionally defrauding Twitter shareholders, who sold their shares based on Musk's statements. The jury found that while Musk was liable for misleading investors with two tweets, including one stating the Twitter deal was "temporarily on hold," he did not do so with a statement he made on a podcast and did not intentionally "scheme" to defraud investors.

The jury awarded shareholders between $3 and $8 per stock per day, but it is unclear what amount in damages Musk will have to pay to thousands of shareholders, many of them institutional investors, with the total likely in the billions. Musk's fortune is currently estimated at about $814 billion, much of it tied up in Tesla shares. The trial focused on Musk's claims about the number of bots on Twitter, with Musk testifying that Twitter had a much higher number of fake and spam accounts than the 5% it disclosed in regulatory filings.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Investor Takeaway

Investors should be cautious of executives' statements and their potential impact on stock prices.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.